Inflammation is associated with increased levels of IGF-1, which is a known potent mitogen for androgen-sensitive and androgen-independent prostate cancer, leading to dysregulation of the PI3K/Akt/mTOR pathway, which plays a key role in the pathogenesis of prostate cancer [16, 36, 40–43]. The gene discussed is AKT1; the disease is prostate carcinoma.